Zai Lab Ltd
(STU:1ZL)
€
16.6
-0.7 (-4.05%)
Market Cap: 1.64 Bil
Enterprise Value: 1.09 Bil
PE Ratio: 0
PB Ratio: 2.40
GF Score: 67/100 - Q4 2023 Zai Lab Ltd Earnings Call TranscriptFeb 28, 2024€19.7 (+3.14%)Earnings
- Zai Lab Ltd at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q3 2023 Zai Lab Ltd Earnings Call TranscriptNov 08, 2023€27.6 (+6.15%)Earnings
- Q2 2023 Zai Lab Ltd Earnings Call TranscriptAug 08, 2023€24Earnings
- Zai Lab Ltd Investor Day TranscriptJun 20, 2023
- Q1 2023 Zai Lab Ltd Earnings Call TranscriptMay 10, 2023€32.2 (+0.63%)Earnings
- Q4 2022 Zai Lab Ltd Earnings Call TranscriptMar 02, 2023€37 (-0.54%)Earnings
- Zai Lab Ltd at Citi BioTech C-Suite Fireside Chat Series (Virtual) TranscriptFeb 14, 2023
- Zai Lab Ltd at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Q3 2022 Zai Lab Ltd Earnings Call TranscriptNov 10, 2022€28.8Earnings
- Zai Lab Ltd at Citi BioPharma Conference TranscriptSep 08, 2022
- Q2 2022 Zai Lab Ltd Earnings Call TranscriptAug 10, 2022€44.8Earnings
- Zai Lab Ltd at Goldman Sachs Global Healthcare Conference TranscriptJun 16, 2022
- Q1 2022 Zai Lab Ltd Earnings Call TranscriptMay 11, 2022€30.6 (+29.66%)Earnings
- Q4 2021 Zai Lab Ltd Earnings Call TranscriptMar 02, 2022€43 (-10.04%)Earnings
- Zai Lab Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Q3 2021 Zai Lab Ltd Earnings Call TranscriptNov 10, 2021€76.5 (+4.08%)Earnings
- Zai Lab Ltd Topline POC Data Readout of ZL-1102 Corporate Call TranscriptOct 21, 2021
- Zai Lab Ltd R&D Day (Virtual) TranscriptSep 22, 2021
- Zai Lab Ltd at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2021
- Q2 2021 Zai Lab Ltd Earnings Call TranscriptAug 10, 2021€130 (+4.84%)Earnings
- Zai Lab Ltd at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Q1 2021 Zai Lab Ltd Earnings Call TranscriptMay 10, 2021€129Earnings
- Full Year 2020 Zai Lab Ltd Earnings Call TranscriptMar 01, 2021€124 (+6.90%)Earnings
- Zai Lab Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Zai Lab Ltd at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2020
- Half Year 2020 Zai Lab Ltd Earnings Call TranscriptAug 13, 2020€68.5 (+3.01%)Earnings
- Zai Lab Ltd at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 11, 2020
- Zai Lab Ltd at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 13, 2020
- Zai Lab Limited - Special Call TranscriptApr 08, 2020
- Q4 2019 Zai Lab Ltd Earnings Call TranscriptMar 19, 2020€42.4 (-5.78%)Earnings
- Zai Lab Ltd at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Q2 2019 Zai Lab Ltd Earnings Call TranscriptSep 03, 2019€29.8 (+2.05%)Earnings
- Zai Lab Ltd and Incyte Corp to Discuss the Collaboration and License Agreement for INCMGA0012 in Greater China Call TranscriptJul 02, 2019
- Zai Lab Ltd at Bank of America Merrill Lynch Health Care Conference TranscriptMay 16, 2019
- Zai Lab Ltd Corporate Analyst Meeting TranscriptApr 30, 2019
- Q4 2018 Zai Lab Ltd Earnings Call TranscriptMar 07, 2019€25.33 (-0.55%)Earnings
Zai Lab Ltd at Citi BioPharma Conference Transcript
Sep 08, 2022 / 12:50PM GMT
Release Date Price:
€43
(-12.96%)
Yigal Dov Nochomovitz
Citigroup Inc., Research Division - Director
Everyone, mainly the people on the webcast, but okay. It's a great pleasure to have senior management from Zai Lab here. I've been following Zai Lab since they were a private company back in 2017. In fact, I've been to China a few times to see their operations. So I want to welcome Billy Cho, CFO; Josh Smiley, COO, who just recently joined the company officially, I think August 1.
Joshua L. Smiley
Zai Lab Limited - COO
That's right. Yes.
Questions & Answers
Yigal Dov Nochomovitz
Citigroup Inc., Research Division - Director
So welcome both of you. I guess at a high level, I think we can just start by a broad strategy question. What is Zai's mission? How are you different from some of your key competitors in the China biotech space? And what's the core investment case for Zai Lab?
Joshua L. Smiley
Zai Lab Limited - COO
Sure. No, thanks, Yigal, and thanks for having us. I think it's pretty
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)